MedTrace Logo

Prediction of IBD Disease Activity in Individual Patients Based on PROMs and Clinical Data

NCT05578768 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2022-10-13

No results posted yet for this study

Summary

The proposed study will use a PROM (Patient report Outcome Measurement)-tool in combination with clinical and biochemical data to train and validate a Relapse Prediction Model for individual patients.

Conditions

  • IBD
  • Inflammatory Bone Disease

Interventions

OTHER

No intervention

Patients will receive standard of care.

Sponsors & Collaborators

  • Alrijne Hospital

    collaborator OTHER

  • Maasstad Hospital

    collaborator OTHER

  • Leiden University Medical Center

    lead OTHER

Principal Investigators

  • A.E. van der Meulen - de Jong, MD, PhD · Leiden University Medical Centre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-03
Primary Completion
2025-09-01
Completion
2025-09-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05578768 on ClinicalTrials.gov